Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Rallybio Corp

Get SEC filing alerts via email and in your feed for Rallybio Corp

RLYB

Rallybio Corp

About Rallybio Corp

Rallybio is a clinical-stage biotechnology company focused on developing therapies for severe and rare diseases. Its pipeline includes product candidates targeting maternal-fetal blood disorders, complement dysregulation, hematology, and metabolic conditions. The company leverages scientific expertise, innovative drug design, and strategic collaborations to create transformative, patient-friendly treatments with high unmet medical needs, aiming to improve outcomes for underserved patient populations worldwide.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Rallybio Corp

1
1
Rallybio Corp Rallybio Corporation Reports $8.3 Million Net Loss in Q1 2026, Maintains Revenue

Via official filing (AI summary) | 22 days ago | 0 comments

2
1
Rallybio Corp Rallybio Reports $8.98 Million Net Loss for Fiscal Year 2025, Announces Merger with Candid

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
Rallybio Corp Rallybio Corporation Reports $16M Net Income in Q3 2025, Driven by Joint Venture Sale

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Rallybio Corp Rallybio Reports Q2 2025 Financial Results, Revenue Declines to $212,000

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Rallybio Corp Rallybio Reports $212,000 Revenue in Q1 2025, Net Loss Improves to $9.4 Million

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Rallybio Corp Rallybio Corp. Reports $57.8 Million Net Loss for 2024, Improved from Previous Year

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
Rallybio Corp Rallybio Reports Reduced Losses, Increased Revenue in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments